GlassScriptPhysician profile
Sharon Althea Smith
NPI 1912151044
$521.71
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $31.89 · 2021: $50.67 · 2022: $236 · 2023: $42.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $42.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $42.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $296.87 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $70.37 | 2019-2020 | |
| Galderma Laboratories, L.P. | $32.38 | 2019 | |
| Allergan, INC. | $24.84 | 2019-2020 | |
| Myovant Sciences INC. | $19.87 | 2021 | |
| Hologic Sales and Service, LLC | $18.19 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.11 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.48 | 2019 | |
| Mission Pharmacal Company | $13.99 | 2019 | |
| Abbvie INC. | $12.61 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.